在直肠癌全新辅助疗法期间,T细胞和内皮细胞的重塑

Qianqian Gao1, Xinnan Ling2, Leen Liao3

  • 1Institute for Data-Driven Tumor Immunology, Chongqing Medical University, Chongqing 400016, China; Institute of Cancer Research, Shenzhen Bay Laboratory, Shenzhen 518132, China.

Cancer cell
|November 7, 2025
PubMed
概括

总的新辅助疗法 (TNT) 通过改变瘤微环境来增强直肠癌治疗. 它减少了调节性T细胞,并增强了CD8+T细胞,促进了免疫反应,并可能改善完整反应率.